News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
108,713 Results
Type
Article (7443)
Company Profile (19)
Press Release (101251)
Multimedia
Podcasts (7)
Webinars (1)
Section
Business (28165)
Career Advice (596)
Deals (4591)
Drug Delivery (13)
Drug Development (13743)
Employer Resources (25)
FDA (3294)
Job Trends (2564)
News (50255)
Policy (4565)
Tag
Academia (691)
Academic (1)
Accelerated approval (2)
Adcomms (2)
Allergies (18)
Alliances (9735)
ALS (31)
Alzheimer's disease (244)
Antibody-drug conjugate (ADC) (14)
Approvals (3277)
Artificial intelligence (100)
Autoimmune disease (4)
Automation (6)
Bankruptcy (38)
Best Places to Work (2142)
BIOSECURE Act (3)
Biosimilars (4)
Biotechnology (14)
Bladder cancer (9)
Brain cancer (9)
Breast cancer (54)
Cancer (430)
Cardiovascular disease (36)
Career advice (455)
Career pathing (6)
CAR-T (28)
Cell therapy (79)
Cervical cancer (3)
Clinical research (11477)
Collaboration (196)
Compensation (19)
Complete response letters (1)
COVID-19 (687)
CRISPR (11)
C-suite (37)
Cystic fibrosis (12)
Data (440)
Decentralized trials (1)
Denatured (6)
Depression (9)
Diabetes (49)
Diagnostics (1604)
Digital health (8)
Diversity, equity & inclusion (5)
Drug discovery (44)
Drug pricing (13)
Duchenne muscular dystrophy (12)
Earnings (8357)
Editorial (6)
Employer branding (4)
Employer resources (22)
Events (12451)
Executive appointments (128)
FDA (3685)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (160)
Gene editing (23)
Generative AI (11)
Gene therapy (83)
GLP-1 (133)
Government (851)
Guidances (8)
Healthcare (2943)
Huntington's disease (5)
IgA nephropathy (4)
Immunology and inflammation (20)
Indications (4)
Infectious disease (731)
Inflammatory bowel disease (10)
Inflation Reduction Act (2)
Influenza (21)
Intellectual property (19)
Interviews (80)
IPO (1715)
IRA (5)
Job creations (495)
Job search strategy (392)
Kidney cancer (2)
Labor market (4)
Layoffs (51)
Leadership (3)
Legal (468)
Liver cancer (21)
Lung cancer (59)
Lymphoma (50)
Machine learning (1)
Management (10)
Manufacturing (64)
MASH (18)
Medical device (2298)
Medtech (2298)
Mergers & acquisitions (2977)
Metabolic disorders (131)
Multiple sclerosis (12)
NASH (2)
Neurodegenerative disease (17)
Neuroscience (375)
NextGen: Class of 2025 (1147)
Non-profit (735)
Obesity (61)
Opinion (45)
Ovarian cancer (18)
Pain (27)
Pancreatic cancer (23)
Parkinson's disease (41)
Partnered (5)
Patents (41)
Patient recruitment (16)
Peanut (10)
People (8111)
Pharmaceutical (3)
Phase I (3235)
Phase II (5259)
Phase III (4233)
Pipeline (242)
Policy (20)
Postmarket research (300)
Preclinical (1124)
Press Release (42)
Prostate cancer (21)
Psychedelics (1)
Radiopharmaceuticals (43)
Rare diseases (61)
Real estate (1085)
Recruiting (13)
Regulatory (3721)
Reports (13)
Research institute (678)
Resumes & cover letters (147)
Rett syndrome (2)
RNA editing (2)
RSV (4)
Schizophrenia (15)
Series A (20)
Series B (10)
Service/supplier (3)
Sickle cell disease (3)
Special edition (2)
Spinal muscular atrophy (50)
Sponsored (7)
Startups (661)
Supply chain (14)
Tariffs (4)
Vaccines (142)
Venture capitalists (9)
Weight loss (32)
Women's health (11)
Worklife (1)
Date
Today (31)
Last 7 days (130)
Last 30 days (453)
Last 365 days (6124)
2025 (2075)
2024 (6308)
2023 (7150)
2022 (10540)
2021 (10531)
2020 (10142)
2019 (7954)
2018 (6338)
2017 (5924)
2016 (5374)
2015 (5951)
2014 (4015)
2013 (3476)
2012 (3538)
2011 (3795)
2010 (3193)
Location
Africa (172)
Alabama (7)
Arizona (25)
Arkansas (4)
Asia (6970)
Australia (1216)
California (1059)
Canada (336)
China (93)
Colorado (48)
Connecticut (60)
Delaware (23)
Europe (15643)
Florida (206)
Georgia (81)
Idaho (3)
Illinois (68)
India (3)
Indiana (39)
Iowa (3)
Japan (41)
Kansas (26)
Kentucky (4)
Maine (5)
Maryland (147)
Massachusetts (723)
Michigan (27)
Minnesota (70)
Missouri (21)
Montana (7)
Nebraska (5)
Nevada (28)
New Hampshire (17)
New Jersey (408)
New Mexico (7)
New York (379)
North Carolina (220)
North Dakota (4)
Northern California (516)
Ohio (39)
Oklahoma (6)
Oregon (5)
Pennsylvania (197)
Puerto Rico (6)
Rhode Island (9)
South America (241)
South Carolina (4)
South Dakota (1)
Southern California (360)
Tennessee (32)
Texas (193)
United States (4177)
Utah (13)
Virginia (29)
Washington D.C. (9)
Washington State (60)
West Virginia (2)
Wisconsin (5)
108,713 Results for "fast biomedical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sungen Biomedical’s world-first new drug SGC001 monoclonal antibody receives FDA fast track approval
March 24, 2025
·
1 min read
Press Releases
Syncell Named One of Fast Company’s Most Innovative Companies of 2025
March 18, 2025
·
2 min read
Press Releases
BioInvent Receives FDA Fast Track Designation for BI-1808 for the Treatment of Cutaneous T-cell Lymphoma
April 29, 2025
·
4 min read
Press Releases
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
March 17, 2025
·
3 min read
Press Releases
Fast Company Recognizes GeneDx as One of the World’s Most Innovative Companies
March 18, 2025
·
5 min read
Press Releases
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
March 26, 2025
·
5 min read
Press Releases
Incyclix Bio Granted U.S. FDA Fast Track Designation for INX-315 to Treat CCNE1-Amplified Platinum-Resistant/Refractory Ovarian Cancer
April 30, 2025
·
2 min read
Press Releases
Cingulate Announces Positive Top-Line Results from High-Dose (50mg) Fed/Fast Study of Lead Asset CTx-1301 for ADHD
April 30, 2025
·
7 min read
Press Releases
Protagonist Therapeutics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025
March 19, 2025
·
6 min read
Press Releases
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
April 10, 2025
·
5 min read
1 of 10,872
Next
